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Abstract
We have previously reported that the host uracil DNA glycosylase UNG2 enzyme is incorporated into HIV-1 virions via a specific
association with the viral integrase (IN) domain of Gag-Pol precursor. In this study, we investigated whether UNG2 was packaged into two
phylogenetically closely related primate lentiviruses, HIV-2ROD and SIVMAC239. We demonstrated by GST-pull-down and coprecipitation
assays that INs from HIV-1, HIV-2ROD, and SIVMAC239 associated with UNG2, although the interaction of UNG2 with HIV-2ROD IN and
SIVMAC239 IN was less strong than with HIV-1 IN. We then showed by Western blotting that highly purified HIV-2 and SIVMAC viral
particles did not incorporate host UNG2, contrasting with the presence of UNG2 in HIV-1 viral particles. Finally, we showed that
HIV-1/SIV chimeric viruses in which residues 6 to 202 of HIV-1 IN were replaced by the SIV counterpart were impaired for packaging
of UNG2, indicating that the incorporation of host UNG2 into viral particles is the hallmark of the HIV-1 strain. Moreover, we found that
HIV-1/SIV IN chimeric viruses were deficient for viral propagation.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Uracil DNA glycosylases belongs to a family of DNA
repair enzymes involved in the base excision repair (BER)
pathway by specifically removing uracil residues from DNA
(for a review, see Krokan et al., 1997). Human cells have
been reported to contain at least six distinct enzymatic
species able to efficiently excise uracil bases from DNA
(Muller and Caradonna, 1993; Neddermann and Jiricny,
1994; Nilsen et al., 1997; Hendrich et al., 1999; Haushalter
et al., 1999). These enzymes include mitochondrial and
nuclear DNA glycosylase isoforms (UNG1 and UNG2, re-
spectively); a cyclin A-like protein (UDG2); thymidine-
DNA glycosylase (TDG); MBD4, a mismatch-specific U/T:
G-DNA glycosylase; and SMUG1, a glycosylase having a
preference for uracil present in single-stranded DNA sub-
strates. In addition to these enzymatic activities, another
distinct class of protein coexists in cells, the deoxyuridine
triphosphatase (dUTPase), which acts directly on the pool of
intracellular nucleotides to prevent misincorporation of ura-
cil residues into DNA by maintaining a low ratio of dUTP
to dTTP.
Genomes of DNA viruses like poxviruses and herpes-
viruses family encode both uracil DNA glycosylase and
dUTPase enzymatic activities. Studies analyzing the prop-
agation in cell culture of UDG-deficient pox- or herpesvi-
ruses revealed a decrease of infectivity, suggesting an im-
portant role for the virally encoded UDG in the viral life
cycle (Pyles and Thompson, 1994; Ellison et al., 1996;
Prichard et al., 1996; Courcelle et al., 2001). Genomes of
Beta retroviruses and nonprimate lentiviruses encode only
dUTPase (Elder et al., 1992). Nonprimate lentiviruses effi-
ciently infect nondividing cells, in which the level of dUTP
is high, thus enhancing the probability of misincorporating
uracil residues during the retrotranscription process. Incor-
poration into DNA of uracil opposite to guanine generates a
promutagenic U:G mismatch, which if not corrected, will
lead to a G-to-A transition mutation in the next round of
DNA replication (Lindahl, 1993). Although the incorpora-
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tion into DNA of uracil opposite to adenine is not directly
mutagenic, uracil in place of thymine in DNA promoter
sequences can alter driven gene expression (Verri et al.,
1990; Focher et al., 1992). The presence of virally encoded
dUTPase indicates that these viruses can locally control the
level of dUTP and prevent incorporation of uracil residues
into their genome. Studies analyzing the replication of
dUTPase-deficient nonprimate CAEV (caprine arthritis-
encephalitis virus) lentiviruses showed an accumulation of
G-to-A mutations in the viral genome and a loss of patho-
genicity (Turelli et al., 1997). dUTPase-deficient nonpri-
mate EIAV (equine infectious anemia virus) lentiviruses
exhibited a reduced replication in macrophages (Steagall et
al., 1995). Altogether, these data demonstrate that the con-
trol of uracil level via the virally encoded UDG or dUTPase
activity is crucial for viral replication.
Genomes of primate lentiviruses encode neither dUTP-
ase nor uracil DNA glycosylase, although they too infect
nondividing cells. In a previous report, we have demon-
strated that host UNG2 is incorporated into HIV-1 viral
particles through a specific interaction with IN (Willetts et
al., 1999). The presence of host UNG2 into HIV-1 virions
highly suggest a role of this DNA repair enzyme in early
events of the HIV-1 life cycle. This localization is reminis-
cent to the presence of virally encoded dUTPase into virions
from nonprimate lentiviruses, and we have proposed that
UNG2 might have a role similar to that played by the
dUTPase in preventing the HIV-1 viral genome toward a
genetic drift.
In this study, we wondered whether closely related pri-
mate lentiviruses, HIV-2ROD and SIVMAC239 have the abil-
ity to incorporate host UNG2 into viral particles. We show
that both HIV-2 and SIVMAC virions were UNG2-deficient,
indicating that HIV-1 have evolved quite differently than
HIV-2 and SIVMAC regarding the ability to incorporate
UNG2. HIV-1/SIV IN chimeric viruses were impaired for
packaging of UNG2 and were impaired for viral propaga-
tion.
Results and discussion
In a previous study, we have demonstrated that UNG2 is
incorporated into HIV-1 viral particles through a specific
interaction with IN (Willetts et al., 1999). We wondered
whether IN from related primate lentiviruses shared the
ability to bind UNG2. INs from HIV-1NL43, HIV-2ROD, and
SIVMAC239 molecular clones fused to glutathione S-trans-
ferase (GST) were bacterially expressed, coupled to gluta-
thione (GSH) agarose beads and GST-IN derivatives were
used in GST pull-down assays with recombinant purified
UNG2. As shown in Fig. 1A (left), UNG2 bound to GST–
HIV-1 IN, and in a lesser extent to GST–HIV-2 IN and
GST–SIV IN. The control GST alone was unable to retain
UNG2. Similar amounts of GST–IN derivatives were used
as judged by Coomassie blue staining (Fig. 1A, right).
To investigate the interaction of IN from HIV-1, HIV-2,
and SIVMAC with UNG2 in a cellular context, HeLa cells
previously infected with recombinant vaccinia virus ex-
pressing T7 polymerase were transfected with plasmids
expressing UNG2 and each of the GST–IN fusion proteins
cloned under the control of the T7 polymerase promoter.
Cell extracts expressed similar level of each of the GST–IN
derivatives and similar amounts of UNG2 (Fig. 1B, left and
middle). Cell lysate was then incubated with GSH–agarose
beads to precipitate GST–IN fusion proteins. Beads were
then recovered by centrifugation, and bound proteins were
revealed by Western blotting with anti-UNG antibody.
UNG2 was present in the precipitated complexes containing
GST–HIV-1 IN, while precipitated complexes containing
GST–HIV-2 IN or GST–SIVMAC IN displayed lower levels
of UNG2 (Fig. 1B, right). As a control, no UNG2 was found
associated with unfused GST proteins. These results indi-
cate that UNG2 preferentially associates with IN belonging
to HIV-1 strain.
Although our results indicate that UNG2 is preferentially
associated with IN from HIV-1 virions, the possibility exists
that the weak interaction of UNG2 with HIV-2 and SIVMAC
IN might be sufficient to allow the packaging of host UNG2
into these viruses. To demonstrate this possibility, HIV-1,
HIV-2, and SIVMAC viruses were purified by sucrose gra-
dient velocity, and viral lysate was resolved on SDS–PAGE
and assayed by Western blotting for the presence of pack-
aged UNG2. As a control, the purified recombinant mito-
chondrial (UNG1) or nuclear (UNG2) isoforms of uracil
DNA glycosylase (a gift from G. Slupphaugh) and a whole-
cell extract were run in parallel. As shown in Fig. 2 (top),
we failed to detect the presence of UNG2 within HIV-2 and
SIVMAC virions, while UNG2 was clearly detectable within
HIV-1 virions. UNG2 into virions comigrates with the
UNG2 but not with the UNG1 isoform, indicating that
UNG1 sequestrated into mitochondria was not a substrate
for IN. Similar amounts of viruses were analyzed as judged
by the presence of capsid (CA) antigen revealed by Coo-
massie blue staining (Fig. 2, bottom). These results demon-
strate that virion-associated UNG2 is specific for HIV-1
strain, but not for HIV-2 or SIVMAC viral strains.
To confirm the role of IN in the packaging of UNG2, we
constructed chimeric HIV-1/SIV viruses in which the region
encompassing amino acids 6 to 202 of HIV-1 IN was
replaced by the one belonging to SIVMAC molecular clone
(Fig. 3A). Viral stocks were obtained by transfection, puri-
fied by ultracentrifugation, and assayed by Western blotting
with anti-UNG antibody. As a control, wild-type HIV-1
(WT) and integrase-deficient HIV-1 (IN) virions were
analyzed in parallel. As expected, IN viruses and HIV-1/
SIV IN chimeric viruses failed to incorporate UNG2 (Fig.
3B), in contrast to wild-type HIV-1 virions. Moreover,
Western blot analysis with anti-Gag and anti-IN antibodies
confirmed that the Gag and Gag-Pol precursors are normally
processed in chimeric viruses. In addition, the Vpr protein
was normally incorporated into HIV-1/SIV IN chimeric
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viruses, confirming that these viruses did not exhibit obvi-
ous protein alterations.
In this article, we demonstrate that the cellular UNG2
enzyme, which plays a role in eliminating uracil residues
misincorporated into DNA, was packaged into HIV-1NL4.3
viral particles, but not into HIV-2ROD, SIVMAC239, or HIV-
1/SIVMAC IN chimeric virions, and that IN was the sole
viral determinant required for the incorporation of UNG2
into viral particles. Although the UNG2 packaging is a
property shared by HIV-1 strains belonging to clade B
(NL4.3 and AD8) and clade D (NDK) (this study and
Willetts et al., 1999), it is still not known whether this
process is a general feature for all HIV-1 clades. The fact
that HIV-2 or SIVMAC virions did not incorporate host
UNG2 suggests that they might have evolved quite differ-
ently from HIV-1. It is possible that UNG2 may associate
with INs of HIV-2 and SIVMAC after entry into the cyto-
plasm of infected cells rather than during budding from the
producing cells. Consistent with this, we showed that both
HIV-2 and SIVMAC IN still retained the ability to interact
with UNG2 in cell as demonstrated by precipitation exper-
iments. Alternatively, HIV-2 and SIVMAC may have the
ability to package another class of uracil DNA glycosylases.
Concerning the functional significance of HIV-1-associ-
ated UNG2, it is well known that the retrotranscription
process is a very early events in the HIV-1 life cycle that
takes place in viral particles to promote at least the minus
strong-stop cDNA product. It is thus conceivable that the
Fig. 1. Association of UNG2 with IN from primate lentiviruses. (A, left) Recombinant purified 6His-tagged UNG2 was incubated in vitro with equivalent
amounts of GST, GST–HIV-1 IN, GST–HIV-2 IN, or GST–SIVMAC IN fusion proteins affinity purified on GSH–agarose beads. After washes, bound proteins
were analyzed by Western blot with anti-UNG antibody. (Right) Amounts of GST–IN derivatives were visualized by Coomassie blue staining. Lane marked
input contains one-fifth of UNG2 before binding to GST. (B) Recombinant vaccinia virus-infected HeLa cells were cotransfected with expression plasmids
containing the T7 polymerase promoter and encoding UNG2 and each of the GST–IN derivatives. The level of expression of GST, GST–IN derivatives, and
UNG2 in cell lysate was analyzed by Western blotting with anti-GST and anti-UNG2 antibody (left and middle). GST–IN derivatives were precipitated by
addition of GSH–agarose beads, and upon extensive washes, bound proteins were resolved by SDS–PAGE and revealed with anti-UNG antibody (right
panel). Mr, molecular mass markers (in kilodaltons).
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presence of this DNA repair enzyme is required at the site
of nascent DNA synthesis to control the fidelity of this
immediate early retrotranscription. In the case of HIV-2 and
SIV, the association of UNG2 and IN in cell might be
sufficient to ensure fidelity replication. Studies are in
progress to demonstrate that HIV-1-associated UNG2 plays
a role similar to that of its cellular counterpart to control the
level of misincorporated uracil residues in DNA.
We and others (Bouhamdan et al., 1996; Selig et al.,
1997; Sleigh et al., 1998) have reported that UNG2 associ-
ates tightly with the HIV-1 Vpr protein. In further studies,
we have demonstrated that HIV-1 viral particles engineered
to be devoid of virion-associated Vpr still retain the ability
to incorporate host UNG2, indicating that Vpr was likely
not required for this process (Willetts et al., 1999). In this
study, we confirm by using HIV-1/SIV IN chimeric viruses
that Vpr did not play an essential role to incorporate endo-
genously expressed UNG2 into virions, although a cooper-
ation of Vpr with IN in this process could not be excluded.
Recent report have indicated that UNG2 expressed in trans
in cells could be docked into HIV-1 viral particles via Vpr
and participated in the reverse transcription accuracy (Man-
sky et al., 2000). This unexpected UNG2 packaging via a
Vpr-dependent pathway could be a consequence of the
abnormally high concentration of both Vpr and UNG2 in
the cytoplasm as they are overexpressed by the very effi-
cient pAS1B plasmid (Mansky et al., 2000), since we dem-
onstrated here that endogenously expressed UNG2 was ex-
clusively docked via a IN-dependent pathway. Moreover,
Mansky and collaborators did not use UNG-specific anti-
bodies, but HA antibodies, and thus could only looked at
HA-tagged-exogenous UNG2, overlooking the endogenous
UNG2 still packaged by the IN pathway. Had they used
truly UNG2 minus virus in their study, the difference in
mutation rate relative to that of their HA–UNG2 plus virus
would have been possibly even higher.
The functional role of the Vpr–UNG2 association still
remains to be fully understood, however. In addition to its
role in the modulation of the mutation rate, the Vpr–UNG2
association could play a role in the nuclear import of the
preintegration complex. Two isoforms of UNG differing in
their N-terminal extremity, UNG2, which contains a nuclear
localisation signal, and UNG1, which contains a mitochon-
drial localization signal (Otterlei et al., 1998), can associate
with Vpr. It has been reported that Vpr, in addition to target
nucleus, can target mitochondria and induce apoptosis (Ja-
cotot et al., 2000). The possibility exists that this differential
targeting may be under the influence of the differential
association of Vpr with UNG2 or UNG1 in infected cells.
A previous study has shown that HIV-1 viruses contain-
ing an HIV-2 IN coding sequence exhibited a marked de-
crease of infectivity (2 orders of magnitude) compared to
wild-type HIV-1 (Liu et al., 1999). We observed that HIV-
1/SIV chimeric viruses were unable to propagate in culture,
indicating that HIV-1 containing an SIV IN coding se-
quence did not support infectivity (data not shown). At this
stage, we do not know whether HIV-1/SIV IN chimeric
virus infection was blocked because the chimeric Gag-Pol
protein was not correcly folded inducing a defect in late
stages of the viral life cycle or whether heterologous SIV IN
itself, in the context of HIV-1, was impaired to ensure viral
DNA synthesis and integration during the early stages of the
viral life cycle. In addition to these possible defects, the
absence of virion-associated UNG2 may participate in the
loss of infectivity.
Materials and methods
Plasmids
Viral molecular clones used in this study were those
from HIV-1NL43, HIV-1AD8, HIV-2ROD, and SIVMAC239. To
generate the chimeric HIV-1 molecular clone with the IN
sequence from SIV, the 3743-bp ApaI–EcoRI of pHIV-1AD8
was subcloned in pBluescript. An artificial unique ClaI
restriction site was then introduced to modify the 15th
nucleotide (A versus C) of the IN open reading frame
without affecting the codon. The 708-bp ClaI–HindIII frag-
ment of HIV-1 IN was deleted by enzymatic digestion and
replaced by the SIVMAC counterpart amplified with primers
containing ClaI and HindIII restriction sites, respectively
(5-ATACCATCGATCCAGCACAAGAAGAACATGAT-
AAA-3 and 5-AGCCCCAAGCTTACCGGGTCCCTTC-
CACAGTTG-3). The 120-bp PacI–HindIII fragment from
Fig. 2. Incorporation of host UNG2 into HIV-1 but not into HIV-2 and
SIVMAC virions. 293T cells were transfected with HIV-1, HIV-2, and
SIVMAC molecular clones, and viruses produced in cell-free supernatant
were collected by ultracentrifugation and resolved on a 20% to 60%
sucrose velocity gradient. Gradient fractions coinciding with the peak of
reverse transcriptase activity were pooled, and amounts of viruses were
normalized by measuring reverse transcriptase activity. Viruses were sol-
ubilized in sample buffer and viral lysate was analyzed by Western blot for
the presence of UNG2. Recombinant UNG1 and UNG2 proteins and a
whole-cell extract from 293T cells were run in parallel (top). Amounts of
viral lysate were estimated by the presence of capsid (CA) antigen revealed
by Coomassie blue staining (bottom). Mr, molecular mass markers (in
kilodaltons).
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SIVMAC IN was then deleted by enzymatic digestion and
replaced by the same fragment from HIV-1 IN obtained by
PCR amplification with a primer containing PacI restriction
site (5-GGG CAG AAA GAT TAA TTA ACA TGA TAG
CAA CAG ACC TAC AAA CTA AA-3) and the primer
containing HindIII restriction site. Finally, the ApaI–EcoRI
fragment was cloned back into pNL43 plasmid to obtain a
HIV-1 molecular clone encoding a chimeric HIV-1 IN gene
with residues 6 to 202 belonging to the SIVMAC strain. The
chimeric HIV-1/SIV IN was checked by sequencing. To
obtain the HIV-1 IN construct, the ClaI restriction site
located into HIV-1 IN was filled in, and the resulting con-
struct encodes only the five first residues of IN. Plasmids
allowing the expression in human cells of GST–IN deriva-
tives and UNG2 under the control of the T7 polymerase
promoter and plasmids allowing prokaryotic expression of
GST–IN derivatives were as previously described (Willetts
et al., 1999).
Fig. 3. HIV-1/SIVMAC viruses containing chimeric IN were deficient for UNG2 packaging. (A) Schematic diagram showing the chimeric HIV-1 IN containing
amino acids 6 to 202 from SIVMAC N protein. (B) 293T cells were transfected with either wild-type (WT) or integrase-deficient HIV-1 (IN) or chimeric
HIV-1/SIV molecular clone containing IN of SIVMAC in the context of HIV-1 background. Viral stocks produced from transfected cells were highly purified
on sucrose gradient velocity and analyzed by Western blot for the presence of virion-associated UNG2 and for the expression of Gag, Vpr, and IN proteins.
Mr, molecular mass markers (in kilodaltons).
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Cell culture and transfection
Human 293T and HeLa cells were cultured in DMEM
(Gibco) supplemented with antibiotics and 10% FCS. Sub-
confluent 293T cells were transfected by the FuGENE 6
transfectant reagent (Roche) according to the manufactur-
er’s protocol. For coprecipitation studies, subconfluent
HeLa cells were infected for 30 min with 1 PFU of recom-
binant vaccinia virus (T7-MVA) (a gift from G. Sutter) per
cell to express T7 RNA polymerase and then transfected
with plasmids expressing GST–IN derivatives and UNG2
cloned under the control of the T7 polymerase promoter.
Protein–protein interactions
The recombinant 6HIS–UNG2 protein was expressed
in bacteria and affinity-purified on nickel column according
to the manufacturer’s recommendations. For GST pull-
down assays, 5 g of immobilized GST–IN derivatives was
incubated with 100 ng of purified 6HIS–UNG2 in binding
buffer as previously described (Willetts et al., 1999). Bound
proteins were resolved on SDS–PAGE and revealed by
Western blotting with rabbit polyclonal anti-UNG antibody
(a gift of G. Slupphaug). For in vivo coprecipitation exper-
iments, extracts from HeLa cells infected with vaccinia
recombinant plasmids and transfected with mammalian ex-
pression plasmids encoding GST–IN derivatives and UNG2
were harvested 20 h posttransfection and lyzed by three
freeze–thawing cycles in a buffer containing 20 mM Tris–
HCl, pH 7.8, 100 mM NaCl, 0.1 mM EDTA, 1 mM DTT,
0.5% NP-40, and a cocktail of antiprotease (Roche). An
aliquot of cell lysate was used to visualize expression of
GST–IN derivatives with rabbit polyclonal anti-GST (Santa
Cruz Biotechnologies). GSH–agarose beads were then
added to the cell lysate and then extensively washed. Bound
proteins were revealed by Western blotting with anti-UNG
antibody.
Virion purification and Western blotting
Viral stocks were obtained by transfection of 293T cells
with plasmids expressing each of the viral molecular clones.
Forty-eight hours posttransfection virions produced in the
cell-free supernatant were collected by ultracentrifugation
and purified through a 20%–60% sucrose gradient velocity.
Gradient fractions coinciding with the peak of reverse tran-
scriptase activity were pooled and normalized for equivalent
amounts of reverse transcriptase activity. Virus pellet was
solubilized in sample buffer, and viral lysate was resolved
on 12% SDS–PAGE and analyzed by Western blot with
rabbit polyclonal anti-UNG, rabbit polyclonal anti-IN (a gift
from D. Trono), and rabbit polyclonal anti-Vpr (a gift of N.
Landau). The primary antibody was revealed by horseradish
peroxidase (HRP)-conjugated secondary antibody (Dako)
and HRP activity was detected by enhanced chemilumines-
cence (ECL, Amersham).
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